ATE443257T1 - Verfahren zur identifizierung von tff2 regulierenden agentien - Google Patents

Verfahren zur identifizierung von tff2 regulierenden agentien

Info

Publication number
ATE443257T1
ATE443257T1 AT04732864T AT04732864T ATE443257T1 AT E443257 T1 ATE443257 T1 AT E443257T1 AT 04732864 T AT04732864 T AT 04732864T AT 04732864 T AT04732864 T AT 04732864T AT E443257 T1 ATE443257 T1 AT E443257T1
Authority
AT
Austria
Prior art keywords
seq
nucleotide sequence
tff2
identifying agents
receptor
Prior art date
Application number
AT04732864T
Other languages
English (en)
Inventor
Patrik Andersson
Nikolai Kouznetsov
Lorenz Poellinger
Stein Petra Von
Original Assignee
Index Pharmaceuticals Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0301395A external-priority patent/SE0301395D0/xx
Application filed by Index Pharmaceuticals Ab filed Critical Index Pharmaceuticals Ab
Application granted granted Critical
Publication of ATE443257T1 publication Critical patent/ATE443257T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5753—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the stomach or small intestine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0331—Animal model for proliferative diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Environmental Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT04732864T 2003-05-14 2004-05-13 Verfahren zur identifizierung von tff2 regulierenden agentien ATE443257T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0301395A SE0301395D0 (sv) 2003-05-14 2003-05-14 Method for identifying TFF2 regulating agents
US47210903P 2003-05-21 2003-05-21
PCT/SE2004/000748 WO2004102195A1 (en) 2003-05-14 2004-05-13 Method for identifying tff2 regulating agents and agents identified using said method

Publications (1)

Publication Number Publication Date
ATE443257T1 true ATE443257T1 (de) 2009-10-15

Family

ID=33455730

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04732864T ATE443257T1 (de) 2003-05-14 2004-05-13 Verfahren zur identifizierung von tff2 regulierenden agentien

Country Status (5)

Country Link
US (1) US7569352B2 (de)
EP (1) EP1625395B1 (de)
AT (1) ATE443257T1 (de)
DE (1) DE602004023189D1 (de)
WO (1) WO2004102195A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011503232A (ja) 2007-11-20 2011-01-27 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド 免疫応答の調節
AU2011282776B2 (en) 2010-07-27 2014-06-12 Boston Medical Center Corporation Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeutics
EP4065602A4 (de) * 2019-11-26 2023-12-27 Alkahest, Inc. Verfahren und zusammensetzungen zum behandeln von altersbedingten beeinträchtigungen mit -trefoilfaktor-familienmitglied 2-modulatoren

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH607170A5 (de) * 1976-10-28 1978-11-30 Sodeco Compteurs De Geneve
US4434010A (en) * 1979-12-28 1984-02-28 Optical Coating Laboratory, Inc. Article and method for forming thin film flakes and coatings
US5059245A (en) * 1979-12-28 1991-10-22 Flex Products, Inc. Ink incorporating optically variable thin film flakes
US5569535A (en) * 1979-12-28 1996-10-29 Flex Products, Inc. High chroma multilayer interference platelets
US5766738A (en) * 1979-12-28 1998-06-16 Flex Products, Inc. Paired optically variable article with paired optically variable structures and ink, paint and foil incorporating the same and method
FR2537898A1 (fr) * 1982-12-21 1984-06-22 Univ Paris Procede de reduction de composes metalliques par les polyols, et poudres metalliques obtenues par ce procede
US4704356A (en) * 1984-03-27 1987-11-03 Rush-Presbyterian-St. Luke's Medical Center Method of diagnosing cartilage tissue abnormalities
US4779898A (en) * 1986-11-21 1988-10-25 Optical Coating Laboratory, Inc. Thin film optically variable article and method having gold to green color shift for currency authentication
US5278590A (en) * 1989-04-26 1994-01-11 Flex Products, Inc. Transparent optically variable device
GB9002360D0 (en) * 1990-02-02 1990-04-04 De La Rue Co Plc Ink composition and components thereof
US5304587A (en) * 1991-12-19 1994-04-19 Moore Business Forms, Inc. Water resistant security ink composition
DE59304894D1 (de) * 1992-12-03 1997-02-06 Ciba Geigy Ag Verfahren zur Herstellung fälschungssicherer farbiger Druckerzeugnisse
US5378822A (en) * 1993-04-08 1995-01-03 Wisconsin Alumni Research Nucleic acids encoding murine and human Ah receptors
US5498283A (en) * 1994-08-23 1996-03-12 Scitex Digital Printing, Inc. Waterfast security inks
GB9601604D0 (en) * 1996-01-26 1996-03-27 Ciba Geigy Ag Pigment compositions
GB9609793D0 (en) * 1996-05-10 1996-07-17 Ciba Geigy Ag Pigment compositions
US5889083A (en) * 1996-09-06 1999-03-30 Videojet Systems International, Inc. Aqueous jet ink compositions
US5720801A (en) * 1996-11-06 1998-02-24 Nadan; Wendy Water resistant security ink composition
US5833994A (en) * 1997-01-08 1998-11-10 Paracelsian, Inc. Use of the AH receptor and AH receptor ligands to treat or prevent cytopathicity of viral infection
US5944881A (en) * 1997-07-25 1999-08-31 The Standard Register Company Tri-component security numbering ink
US5980593A (en) * 1998-02-13 1999-11-09 Morton International, Inc. Silent fluorescent petroleum markers
AUPQ146199A0 (en) * 1999-07-07 1999-07-29 Note Printing Australia Limited Improved security document or device
US6938013B1 (en) * 2000-01-05 2005-08-30 Uniteller Financial Services, Inc. Money-transfer techniques
JP4408171B2 (ja) * 2000-06-23 2010-02-03 日立オムロンターミナルソリューションズ株式会社 現金自動取引システム
GB0015871D0 (en) * 2000-06-28 2000-08-23 Rue De Int Ltd A security device
EP1328652B1 (de) * 2000-10-26 2006-02-15 Index Pharmaceuticals AB Nicht-menschliches transgenes tier, welches ca-ahr exprimiert
US20020120916A1 (en) * 2001-01-16 2002-08-29 Snider Albert Monroe Head-up display system utilizing fluorescent material
US6712894B2 (en) * 2001-05-09 2004-03-30 Cabot Corporation Method of producing secure images using inks comprising modified pigment particles
JP2002334971A (ja) * 2001-05-09 2002-11-22 Nec Corp 磁性メモリ及びその動作方法
CA2459235C (en) * 2001-09-03 2009-11-10 Basf Aktiengesellschaft Method for increasing the whiteness of paper by means of cationic polyelectrolytes
US20060159838A1 (en) * 2005-01-14 2006-07-20 Cabot Corporation Controlling ink migration during the formation of printable electronic features
AU2002363192A1 (en) * 2001-11-01 2003-05-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ink-jet inks containing metal nanoparticles
US8363323B2 (en) * 2002-04-03 2013-01-29 De La Rue International Limited Optically variable security device and method
DE10222660A1 (de) * 2002-05-22 2003-12-04 Linde Ag Verfahren und Vorrichtung zum Hochgeschwindigkeits-Flammspritzen
US7708974B2 (en) * 2002-12-10 2010-05-04 Ppg Industries Ohio, Inc. Tungsten comprising nanomaterials and related nanotechnology
US8210120B2 (en) * 2003-01-10 2012-07-03 Microsemi Corporation Systems and methods for building tamper resistant coatings
US20050192888A1 (en) * 2003-10-31 2005-09-01 Lennane James P. System and method to instantaneously settle a securities transaction over a network
US8062735B2 (en) * 2004-04-13 2011-11-22 L-1 Secure Credentialing, Inc. Retroreflective security features in secure documents
US20060083694A1 (en) * 2004-08-07 2006-04-20 Cabot Corporation Multi-component particles comprising inorganic nanoparticles distributed in an organic matrix and processes for making and using same
TW200640596A (en) * 2005-01-14 2006-12-01 Cabot Corp Production of metal nanoparticles
US20060160373A1 (en) * 2005-01-14 2006-07-20 Cabot Corporation Processes for planarizing substrates and encapsulating printable electronic features
US20060165898A1 (en) * 2005-01-21 2006-07-27 Cabot Corporation Controlling flame temperature in a flame spray reaction process

Also Published As

Publication number Publication date
US20070042434A1 (en) 2007-02-22
WO2004102195A1 (en) 2004-11-25
EP1625395A1 (de) 2006-02-15
WO2004102195A8 (en) 2005-02-03
DE602004023189D1 (de) 2009-10-29
US7569352B2 (en) 2009-08-04
EP1625395B1 (de) 2009-09-16

Similar Documents

Publication Publication Date Title
PT1548032E (pt) Péptidos kdr e vacinas que os contêm
SG142154A1 (en) Methods for genomic analysis
JO2373B1 (en) W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors
GEP20146050B (en) Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
IL221366A0 (en) SOLUBLE zB7RI POLYPEPTIDE AND METHOD USING IT
ATE553192T1 (de) Eine dna-zielsequenz von einem xeroderma pigmentosum-gen abspaltende meganukleasevarianten und ihre verwendung
MXPA05005398A (es) Meta para terapia de deterioro cognitivo.
MY139138A (en) Antifouling compositions comprising a polymer with salt groups
ATE455792T1 (de) Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon
GB0713183D0 (en) Method
DE60129805D1 (de) Genetisches testverfahren zur bestimmung des risikos der entwicklung von pouchitis
JP2021525770A5 (de)
ATE536745T1 (de) Zusammensetzung mit arazym zur prävention und behandlung von krebs
DK1730315T3 (da) Polymorphismer i NOD2/Card15 gen
ATE443257T1 (de) Verfahren zur identifizierung von tff2 regulierenden agentien
MX2007006090A (es) 2-metilen-19-nor-(20r)-1a-hidroxi-bishomopregnacalciferol.
Broker et al. Clinical aspects and polymorphisms in the LTA, TNFA, LTB genes and association with dental implant loss
WO2007013358A3 (en) Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent
ATE389017T1 (de) Verfahren zur selektiven hemmung des menschlichen n-myc-gens in n-myc exprimierenden tumoren durch antisense- und sense-peptidonukleinsäuren (pna)
ATE325812T1 (de) Menschliches, gebärmutterkrebs-spezifisches suppressorprotein, für das protein kodieres polynukleotid, mit dem polynukleotid transformierte zelle und verfahren zur unterdrückung der proliferation von krebszellen unter verwendung des expressionsvektors
ATE357530T1 (de) Verfahren zum ändern der expression von hyphen- spezifischen genen
Ronchi et al. MALT gastric lymphoma: An update of pathogenetic features
WO2008060602A3 (en) Polymorphisms in the urocortin 3 gene and their associations with marbling and subcutaneous fat depth in beef cattle
WO2009014160A1 (ja) 膵癌の新規腫瘍マーカー
DE60330565D1 (de) Anti-fragilis Antikörper und dessen Verwendungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties